Gallbladder and Biliary Tract Diseases — MCQs
A patient who is on treatment for hyperlipidemia develops gallstones. What is the mechanism of action of the causative drug that was given to this patient?
Which of the following is not a risk factor for cholangiocarcinoma?
Which of the following substances is NOT typically found in gallstones?
Which of the following statements is true regarding gallbladder carcinoma?
Which of the following is least likely to be a cause of cholecystitis?
Mallory bodies are typically seen in all of the following conditions except:
Micronodular cirrhosis is seen in all except:
In a patient presenting with jaundice, the HIDA scan would be most useful for which of the following:
Regarding carcinoma gall bladder following features are true except:
The following procedure is performed for the management of?
Gallbladder and Biliary Tract Diseases Indian Medical PG Practice Questions and MCQs
Question 1: A patient who is on treatment for hyperlipidemia develops gallstones. What is the mechanism of action of the causative drug that was given to this patient?
- A. Binds to deoxycholic acid
- B. Decreases VLDL
- C. Activates PPAR alpha (Correct Answer)
- D. Inhibits HMG CoA reductase
Explanation: ***Activates PPAR alpha*** * Activation of **PPAR alpha (Peroxisome Proliferator-Activated Receptor alpha)** by fibrates can lead to increased cholesterol secretion into bile [1]. * This increased biliary cholesterol saturation predisposes patients to **cholesterol gallstone** formation. *Decreases VLDL* * While fibrates do decrease **VLDL (Very Low-Density Lipoprotein)** production, this specific action is not the primary mechanism by which they cause gallstones [1]. * The reduction in VLDL is beneficial for triglyceride lowering, but the gallstone risk relates to cholesterol metabolism. *Binds to deoxycholic acid* * This mechanism is characteristic of **bile acid sequestrants** like cholestyramine, which bind to bile acids in the gut to prevent their reabsorption. * Bile acid sequestrants are not typically associated with an increased risk of gallstones; in fact, they can sometimes be used to reduce gallstones in specific contexts. *Inhibits HMG CoA reductase* * This is the mechanism of action for **statins**, which are highly effective in lowering LDL cholesterol by inhibiting the rate-limiting enzyme in cholesterol synthesis [2]. * Statins are not generally associated with an increased risk of gallstones; some studies even suggest a potential protective effect [3].
Question 2: Which of the following is not a risk factor for cholangiocarcinoma?
- A. Thorotrast
- B. Radon
- C. Dioxin
- D. Aflatoxin (Correct Answer)
Explanation: ***Aflatoxin*** - **Aflatoxin** is a potent **hepatocarcinogen** produced by *Aspergillus* species that is specifically and strongly linked to **hepatocellular carcinoma (HCC)** [1], NOT cholangiocarcinoma. - This is the **most clearly unrelated** risk factor to cholangiocarcinoma among the options, as its carcinogenic mechanism targets hepatocytes specifically [1], [2]. - It contaminates crops in warm, humid regions and is a well-established cause of liver cancer in endemic areas [1]. *Thorotrast* - **Thorotrast** (thorium dioxide) was a radioactive contrast agent used until the 1950s that **IS a known risk factor** for cholangiocarcinoma. - Due to prolonged retention in the liver and biliary system, it significantly increases the risk of both **cholangiocarcinoma** and **hepatic angiosarcoma** [3]. - Its use was discontinued precisely because of its strong carcinogenic potential. *Radon* - **Radon** is a naturally occurring radioactive gas that is primarily and overwhelmingly associated with **lung cancer** from inhalation exposure. - While a potent carcinogen, it has **no established epidemiological link** to cholangiocarcinoma due to its route of exposure and target organ. *Dioxin* - **Dioxins** are environmental pollutants with documented carcinogenic effects. - While some studies have explored potential links to various cancers, dioxin is **not recognized as an established risk factor** for cholangiocarcinoma in major medical references. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 331-332. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 216-217.
Question 3: Which of the following substances is NOT typically found in gallstones?
- A. Cholesterol
- B. Oxalates (Correct Answer)
- C. Phosphate
- D. Carbonate
Explanation: ***Oxalates*** - Gallstones are primarily composed of **cholesterol**, **bile pigments**, and **calcium salts**, but they do not contain oxalates [1][2][3]. - Oxalates are more commonly associated with **kidney stones**, making this correct. *Carbonate* - Gallstones can contain **calcium carbonate**, particularly in certain types of stones, indicating that this option is incorrect. - These stones are formed in the **gallbladder**, often due to altered bile composition [2]. *Phosphate* - Some gallstones can contain **calcium phosphate**, especially in cases of infection or liver disease, which makes this option unsuitable. - Phosphate can contribute to the formation of **mixed stones** in the gallbladder. *Cholesterol* - In fact, the most common type of gallstone is the **cholesterol stone**, indicating that this option is incorrect [1][3]. - Cholesterol stones form when there is excessive **cholesterol** in the bile, leading to crystallization [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 882-883. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 403-404. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 882.
Question 4: Which of the following statements is true regarding gallbladder carcinoma?
- A. 30% are squamous cell carcinoma
- B. 5-year survival is approximately 25%
- C. Most commonly presents with abdominal pain and weight loss
- D. 90% associated with gallstones (Correct Answer)
Explanation: 90% associated with gallstones - The vast majority of gallbladder carcinomas are linked to **gallstone disease**, which is considered a major risk factor due to chronic inflammation [2]. - This strong association highlights the role of prolonged irritation in the development of malignancy in the gallbladder. *Most commonly presents with abdominal pain and weight loss* - While **abdominal pain** and **weight loss** can be symptoms, they are non-specific and often present at advanced stages [1]. - Earlier symptoms might include **jaundice** or **right upper quadrant discomfort**, but these are also often vague [1]. *5-year survival is approximately 25%* - The overall 5-year survival rate for gallbladder carcinoma is significantly lower, typically ranging from **5-10%**, making it one of the more lethal cancers. - The poor prognosis is often due to late diagnosis, as symptoms usually appear when the disease is already advanced and has metastasized; death typically occurs within 1 year in symptomatic patients [1]. *30% are squamous cell carcinoma* - The vast majority of gallbladder carcinomas (approximately **90%**) are **adenocarcinomas**. - Squamous cell carcinoma and other rare types represent only a small minority of cases.
Question 5: Which of the following is least likely to be a cause of cholecystitis?
- A. OCP
- B. Estrogen (Correct Answer)
- C. Diabetes mellitus
- D. Obesity
Explanation: ### Estrogen - While **estrogen** can contribute to the formation of gallstones (cholelithiasis) by increasing cholesterol secretion into bile, it is **least directly implicated** as a primary cause of cholecystitis itself [1]. - Cholecystitis is primarily caused by **gallstone obstruction** of the cystic duct or, less commonly, by acalculous inflammation [1]. ### OCP - **Oral contraceptive pills (OCPs)** contain estrogen, which is a known risk factor for the formation of **gallstones**, leading to cholelithiasis [1]. - Gallstones are the most common cause of **acute cholecystitis** due to obstruction of the cystic duct [1]. ### Diabetes mellitus - **Diabetes mellitus** increases the risk of gallstone formation due to **impaired gallbladder motility** and changes in bile composition. - Diabetic patients are also at higher risk for severe cholecystitis and complications, including **gangrenous cholecystitis** or emphysematous cholecystitis [1]. ### Obesity - **Obesity** is a significant risk factor for the development of **cholesterol gallstones** due to increased cholesterol synthesis and secretion into bile [1]. - The presence of gallstones, or cholelithiasis, is the primary predisposing factor for **acute cholecystitis** [1].
Question 6: Mallory bodies are typically seen in all of the following conditions except:
- A. Primary biliary cirrhosis
- B. Hepatocellular carcinoma
- C. Neonatal hepatitis (Correct Answer)
- D. Alcoholic liver disease
Explanation: ***Neonatal hepatitis (does not present with Mallory bodies)*** - Mallory bodies are typically absent in neonatal hepatitis, which often presents with **hepatocellular necrosis** but not the characteristic cytoplasmic inclusions. - The condition predominantly affects newborns and is associated with **viral infections** rather than alcoholic injury leading to Mallory bodies. *Hepatocellular carcinoma* - Hepatocellular carcinoma may show **Mallory bodies**, particularly in cases that have underlying liver disease such as cirrhosis [2][3]. - They may also appear in the setting of **alcohol-related liver conditions** that can predate the carcinoma [1][4]. *Alcoholic liver disease* - Mallory bodies are a classic finding in alcoholic liver disease, forming due to **cytoskeletal damage** from alcohol metabolism [1][4][5]. - The presence of these bodies, along with **steatosis**, indicates severe liver injury related to alcohol consumption [1][4]. *Indian childhood cirrhosis* - This condition is associated with Mallory bodies and represents **cholestatic liver disease** linked to **nutritional deficiencies** and malabsorption in children. - Histologically, it shares features with alcoholic liver disease, including the presence of these abnormal inclusions [1][4]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 852. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 852-854. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 848-850.
Question 7: Micronodular cirrhosis is seen in all except:
- A. Hemochromatosis
- B. Chronic extrahepatic biliary obstruction
- C. Chronic hepatitis B (Correct Answer)
- D. Alcoholic liver disease
Explanation: ***Chronic hepatitis B*** - **Chronic hepatitis B** typically leads to **macronodular cirrhosis**, characterized by large, irregularly sized regenerative nodules separated by broad fibrous septa. - The liver architecture in macronodular cirrhosis is severely disrupted, with nodules often exceeding 3 mm in diameter. *Alcoholic liver disease* - **Alcoholic liver disease** commonly progresses to **micronodular cirrhosis**, which features small, uniformly sized regenerative nodules (typically <3 mm) surrounded by delicate fibrous septa [1]. - This pattern is due to the sustained effect of alcohol on hepatocytes and stellate cells, leading to continuous fibrosis. *Hemochromatosis* - **Hemochromatosis**, particularly advanced stages, often results in **micronodular cirrhosis** due to the progressive deposition of iron in hepatocytes, which causes chronic injury and fibrogenesis [1]. - The widespread iron deposition promotes diffuse fibrosis and the formation of numerous small regenerative nodules. *Chronic extrahepatic biliary obstruction* - **Chronic extrahepatic biliary obstruction** leads to **biliary cirrhosis**, which is typically **micronodular** in its early stages. - Prolonged cholestasis causes inflammation and periductal fibrosis, leading to the formation of small nodules and a characteristic "hobnail" appearance of the liver surface. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-396.
Question 8: In a patient presenting with jaundice, the HIDA scan would be most useful for which of the following:
- A. Biliary atresia (Correct Answer)
- B. Cholelithiasis
- C. Benign biliary disease
- D. Bile duct carcinoma
Explanation: ***Biliary atresia*** - A **HIDA scan** (hepatobiliary iminodiacetic acid scan) is instrumental in diagnosing biliary atresia by demonstrating the **absence of bile flow** into the duodenum. - In infants with persistent jaundice, the failure of the tracer to appear in the small bowel after a prolonged period strongly suggests this condition, indicating **obstructed or absent bile ducts**. *Cholelithiasis* - While HIDA scans can detect **cystic duct obstruction** in acute cholecystitis, they are less definitive for uncomplicated cholelithiasis (gallstones without acute inflammation). - **Ultrasound** is typically the primary imaging modality for diagnosing gallstones due to its non-invasiveness and ability to visualize stones directly. *Benign biliary disease* - This is a broad category, and while a HIDA scan can assess bile flow, it's not the **primary diagnostic tool** for all benign biliary conditions. - For most benign biliary diseases (e.g., choledocholithiasis without acute cholecystitis), **ultrasound, ERCP, or MRCP** often provide more detailed anatomical information. *Bile duct carcinoma* - A HIDA scan might show **obstructed bile flow** in bile duct carcinoma (cholangiocarcinoma), but it does not provide the detailed anatomical information or staging necessary for diagnosis and treatment planning. - **CT, MRI, MRCP, or ERCP** with biopsy are far more effective for identifying, characterizing, and staging bile duct malignancies.
Question 9: Regarding carcinoma gall bladder following features are true except:
- A. One can have similar presentation with benign biliary disease
- B. Squamous cell carcinoma is 40% of all cases (Correct Answer)
- C. Most patients present with advanced disease
- D. Prognosis is poor
Explanation: ***Squamous cell carcinoma is 40% of all cases*** - This statement is incorrect because **adenocarcinoma** accounts for approximately 90% of all gallbladder carcinomas, while squamous cell carcinoma is rare, representing only about 1-5% of cases. - The vast majority of gallbladder cancers are of glandular origin, reflecting the epithelial lining of the organ. *One can have similar presentation with benign biliary disease* - This is true because symptoms of gallbladder carcinoma such as **right upper quadrant pain**, nausea, and jaundice can mimic those of **gallstones** or cholecystitis, leading to delayed diagnosis. - The **non-specific nature** of early symptoms makes differentiation from benign conditions challenging without further investigation. *Most patients present with advanced disease* - This is true due to the gallbladder's deep anatomical location and the **non-specific nature** of early symptoms, leading to late detection. - Consequently, by the time symptoms become significant enough for diagnosis, the cancer has often **metastasized** or invaded surrounding structures. *Prognosis is poor* - This is true, largely because the disease is typically diagnosed at an **advanced stage** with regional or distant metastasis. - The **aggressive biological behavior** of gallbladder cancer and its resistance to conventional therapies also contribute to a poor prognosis.
Question 10: The following procedure is performed for the management of?
- A. Gallbladder carcinoma
- B. Distal cholangiocarcinoma (Correct Answer)
- C. Chronic calcific pancreatitis
- D. Advanced gastric carcinoma
Explanation: ***Distal cholangiocarcinoma*** - The image shows a **Pylorus-preserving Whipple procedure (PPPD)**, which involves resection of the pancreatic head, duodenum, gallbladder, and part of the common bile duct, followed by reconstruction. - This procedure is primarily performed for malignancies of the **pancreatic head**, **distal bile duct (cholangiocarcinoma)**, and **ampulla of Vater**, as they often cause obstructive jaundice and are resectable. *Gallbladder carcinoma* - While gallbladder carcinoma can involve the bile ducts, this specific reconstruction (PPPD) is more commonly associated with tumors of the pancreatic head or distal bile duct rather than the gallbladder itself, which might be managed with a **cholecystectomy** and possibly **liver resection**. - The type of resection and reconstruction varies significantly based on the extent and location of gallbladder cancer. *Chronic calcific pancreatitis* - Surgical management for chronic pancreatitis, especially with calcifications, typically involves drainage procedures (e.g., **Puestow procedure** due to dilated pancreatic duct or **Frey procedure**) or resection of the pancreatic head (e.g., **Beger procedure**). - While some resections of the pancreatic head are performed for chronic pancreatitis, the depicted procedure is specifically designed for malignancies of the pancreatic head region, not primarily for the sequelae of chronic calcific pancreatitis unless associated with a mass suspicious for malignancy. *Advanced gastric carcinoma* - Advanced gastric carcinoma is typically managed by **gastrectomy** (partial or total) with lymphadenectomy, not a Whipple procedure. - The image clearly shows an **intact pylorus** and the stomach mostly preserved, which is inconsistent with advanced gastric carcinoma requiring major gastric resection.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free